NKX3-2 and brain glioma: Six different datasets representing different solid tumors (including ovarian cancer, brain glioma, colorectal adenocarcinoma, kidney carcinoma, liver cancer, and breast-invasive carcinoma) were considered, and all of them showed a similar trend, indicating that NKX3-2 is a negative prognostic marker.